Scholars Central

Case reportPublished 2017

Cabergoline (Dostinex) Effect on Weight Ovarian Function

Authors: Rawa Jaafar Kadhim Al-Ameri

Family Medicine & Medical Science Research

Volume 6 · Issue 2 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cabergoline’s common brand name (Dostinex) is a long-acting dopamine receptor agonist, blocks prolactin secretion from the pituitary gland. It is used in Inhibition of physiological lactation, hyperprolactinaemia-associated disorders as polycystic ovarian syndrome, pituitary adenoma, and in Parkinson's disease; adjunct to levodopa treatment in Parkinson's disease. Common side effects of cabergoline; nausea, stomach upset, vomiting, constipation, heartburn, dizziness, tiredness, numbness, burning, and tingling in the hands, arms, legs, or feet. This report of two cases, take cabergoline showed a reduction in weight, resuming steady ovulation and regular menstruation after cabergoline treatment, with a possible side effect that these two cases developed follicular cyst following cabergoline treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Family Medicine & Medical Science Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalFamily Medicine & Medical Science Research
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Rawa Jaafar Kadhim Al-Ameri”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels